MoonLake Immunotherapeutics (MLTX) Cash from Operations (QoQ) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.38 Bn | 1.02 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.74% |
| Dec 31, 2025 | -31.99% |
| Sep 30, 2025 | 18.31% |
| Jun 30, 2025 | -42.97% |
| Mar 31, 2025 | 21.32% |
| Dec 31, 2024 | -91.77% |
| Sep 30, 2024 | 9.37% |
| Jun 30, 2024 | -86.58% |
| Mar 31, 2024 | -21.09% |
| Dec 31, 2023 | -33.44% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | -34.73% |
| Mar 31, 2023 | 22.18% |
| Dec 31, 2022 | -24.00% |
| Sep 30, 2022 | 54.95% |
| Jun 30, 2022 | -46.34% |
| Mar 31, 2022 | 59.67% |
| Dec 31, 2021 | -1,642.55% |
| Sep 30, 2021 | 92.11% |
| Jun 30, 2021 | -23,645.79% |